Skip to Main Content
TABLE 1

Patients and control individuals

P-DRB1*-A, -B*P-DRB1*-A, -B*C-DRB1*-A, -B*
R1 03/04 A2–3, B18–38 R20 03/04 A1–24, B8- C1 nd A2–29, B7–44 
R2 04/13 A2–24, B27- R21 03/04 A24–25, B18–56 C2 nd A2–3, B38–51 
R3 03/11 A2–30, B16–18 R22 03/03 A1–24, B16–39 C3 nd A24–28, B7–8 
R4 03/16 A2-, B45–18 R23 04/08 A3–24, B39–49 C4 nd A1–30, B8–13 
R5 01/03 A2-, B8- R24 04/08 A24–80, B44–51 C5 nd A1–32, B8–13 
R6 03/16 A2–11, B7–55 R25 03/03 A9–10, B8–14 C6 nd A2–31, B35–60 
R7 03/04 A2-, B62–52 R26 03/04 A1–2, B8–15 C7 nd A2-, B8- 
R8 03/04 A2-, B8–44 L1 03/04 A2-, B35–62 C8 nd A2–3, B7–12 
R9 03/11 A2-, B8–51 L2 03/04 A2–29, B7–35 C9 nd A2-, B27–44 
R10 04/04 A2–3, B14–44 L3 01/01 A2–24, B7–35 C10 03/04 A1–2, B8–50 
R11 04/13 A2–3, B15–50 L4 04/04 A2-, B39–62 C11 nd A2–3, B7–50 
R12 01/04 A2–3, B15–35 L5 03/03 A1–24, B8–45 C12 nd A1–3, B8–27 
R13 03/04 A2–24, B49- L6 03/04 A1–24, B8–49 D1 nd A2–10, B12–44 
R14 07/13 A1–2, B12–44 L7 04/13 A11–24, B50–62 D2 03/15 A2-, B35–44 
R15 03/13 A2-, B8- L8 03/04 A1–3, B8–49 D3 03/14 A1–11, B8–55 
R16 03/04 A2–3, B8–18 L9 03/03 A3–31, B8–51 D4 03/13 A2-, B38–45 
R17 04/16 A1–24, B8–44 L10 03/04 A1–9, B8–21 D5 01/11 A1–2, B7- 
R18 03/08 A3–24, B8–58 L11 03/04 A1-, B8–38 D6 03/07 A1–19, B8–44 
R19 01/04 A3–24, B35–47 L12 03/04 A1-, B8–44    
P-DRB1*-A, -B*P-DRB1*-A, -B*C-DRB1*-A, -B*
R1 03/04 A2–3, B18–38 R20 03/04 A1–24, B8- C1 nd A2–29, B7–44 
R2 04/13 A2–24, B27- R21 03/04 A24–25, B18–56 C2 nd A2–3, B38–51 
R3 03/11 A2–30, B16–18 R22 03/03 A1–24, B16–39 C3 nd A24–28, B7–8 
R4 03/16 A2-, B45–18 R23 04/08 A3–24, B39–49 C4 nd A1–30, B8–13 
R5 01/03 A2-, B8- R24 04/08 A24–80, B44–51 C5 nd A1–32, B8–13 
R6 03/16 A2–11, B7–55 R25 03/03 A9–10, B8–14 C6 nd A2–31, B35–60 
R7 03/04 A2-, B62–52 R26 03/04 A1–2, B8–15 C7 nd A2-, B8- 
R8 03/04 A2-, B8–44 L1 03/04 A2-, B35–62 C8 nd A2–3, B7–12 
R9 03/11 A2-, B8–51 L2 03/04 A2–29, B7–35 C9 nd A2-, B27–44 
R10 04/04 A2–3, B14–44 L3 01/01 A2–24, B7–35 C10 03/04 A1–2, B8–50 
R11 04/13 A2–3, B15–50 L4 04/04 A2-, B39–62 C11 nd A2–3, B7–50 
R12 01/04 A2–3, B15–35 L5 03/03 A1–24, B8–45 C12 nd A1–3, B8–27 
R13 03/04 A2–24, B49- L6 03/04 A1–24, B8–49 D1 nd A2–10, B12–44 
R14 07/13 A1–2, B12–44 L7 04/13 A11–24, B50–62 D2 03/15 A2-, B35–44 
R15 03/13 A2-, B8- L8 03/04 A1–3, B8–49 D3 03/14 A1–11, B8–55 
R16 03/04 A2–3, B8–18 L9 03/03 A3–31, B8–51 D4 03/13 A2-, B38–45 
R17 04/16 A1–24, B8–44 L10 03/04 A1–9, B8–21 D5 01/11 A1–2, B7- 
R18 03/08 A3–24, B8–58 L11 03/04 A1-, B8–38 D6 03/07 A1–19, B8–44 
R19 01/04 A3–24, B35–47 L12 03/04 A1-, B8–44    

P, patients; R, recent-onset diabetes; L, long-standing diabetes; C, healthy control subjects; D, type 2 diabetic control subjects; nd, not done.

*

HLA alleles.

Insulin treated.

Close Modal

or Create an Account

Close Modal
Close Modal